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МЕТОДИЧНІ АСПЕКТИ ВИКЛАДАННЯ СТАНДАРТИЗАЦІЇ 
ЛІКАРСЬКИХ ЗАСОБІВ ІНОЗЕМНИМ СТУДЕНТАМ
The aim of the work – to  nd ways to solve the main problems faced by teachers working with foreign students in the discipline 
“Standardization of medicines”; analyze the main issues that can affect the performance of the training of foreign students.
The main body. The research is based on the study of materials obtained from open sources of information and authors’ own experience. 
The article presents modern technologies of teaching and testing of foreign students on “Standardization of medicines”,  approved at 
the Department of Pharmaceutical Chemistry.
Since the quality of the drug is laid down at the stage of pharmaceutical development, the student must clearly know the elements of 
pharmaceutical development. The purpose of pharmaceutical development is to develop a quality drug and the process of its production, 
in order to continuously produce products with given functional characteristics and competitiveness in the pharmaceutical market. 
The future specialist in the pharmaceutical industry needs to learn to choose, in accordance with the pharmaceutical form, analytical 
methods for controlling the quality of the medicines and make the speci cations and be guided in the practical activities of the MCQ on 
the FDF. Detailed and thorough acquaintance with the basics of the discipline “Standardization of medicines”,  gives the opportunity 
to more fully master the studied material, realize the scienti c and creative potential of students, enrich their knowledge, which will be 
directly used in their practical activities.
Conclusion. The proposed method allows the teacher to successfully build an educational process, which ultimately positively affects 
the overall mastering of the course.
Key words: standardization; pharmaceutical development; Pharmacopoeia.
Мета роботи – знайти шляхи вирішення основних проблем, з якими стикаються викладачі, що працюють зі студен тами-
іноземцями при викладанні дисципліни “Стандартизація лікарських засобів”. Проаналізувати основні проблеми, які можуть 
впливати на результативність навчання студентів-іноземців. 
Основна частина. Дослідження базується на вивченні матеріалів, отриманих із відкритих джерел інфор мації та власного 
досвіду авторів. У статті наведені сучасні технології викладання та тестування іноземних студентів зі стандартизації лікарських 
засобів, впроваджені на кафедрі фармацевтичної хімії. 
Оскільки якість препарату закладається ще на етапі фармацевтичної розробки, студент чітко повинен знати елементи фарма-
цевтичної розробки. Ціллю фармацевтичної розробки є: розробити якісний препарат і процес його виробництва, щоб постійно 
випускати продукцію із заданими функціональними характеристиками та конкурентоспроможністю на фармацевтичному ринку. 
Майбутньому фахівцю у фармацевтичній галузі необхідно навчитися вибирати відповідно до лікарської форми аналітичні ме-
тодики для контролю якості ЛЗ і складати специфікації та керуватися в практичній діяльності згідно з МКЯ на ГЛЗ. Детальне 
і ґрунтовне ознайомлення з основами дисципліни “Стандартизація лікарських засобів” дає можливість більш повно засвоїти 
матеріал, що вивчається, реалізувати науково-творчий потенціал студентів, збагачує їх знаннями, які безпосередньо будуть 
використані у їхній практичній діяльності.
Висновок. Запропонований метод дозволяє викладачеві успішніше будувати освітній процес, що, в кінцевому підсумку, по-
зитивно позначається на загальному засвоєнні курсу. 
Ключові слова: стандартизація; фармацевтична розробка; Фармакопея.
Introduction. The pharmaceutical industry of the 
European Union maintains high standards of Quality 
Management in the development, manufacture and 
control of medicinal products. A system of marketing 
authorisations ensures that all medicinal products are 
assessed by a competent authority to ensure compliance 
with contemporary requirements of safety, quality and 
ef cacy. A system of manufacturing authorisations 
ensures that all products authorised on the European 
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market are manufactured / imported only by authorised 
manufacturers, whose activities are regularly inspected 
by the competent authorities, using Quality Risk 
Management principles. Manufacturing authorisations 
are required by all pharmaceutical manufacturers in the 
European Union whether the products are sold within 
or outside of the Union. To do this, it is necessary to 
rationalize the organization of the entire educational 
process, to improve the content, forms, methods of 
teaching and learning activity of students of higher 
educational institutions [1, 2].  
The aim of the work – to  nd ways to solve the 
main problems faced by teachers working with 
foreign students in the discipline “Standardization of 
medicines”; analyze the main issues that can affect the 
performance of the training of foreign students. 
The main body. The research is based on the study 
of materials obtained from open sources of information 
and authors’ own experience. The article presents 
modern technologies of teaching and testing of foreign 
students on “Standardization of medicines”,  approved 
at the Department of Pharmaceutical Chemistry.
The aim of the subject “Standardization of medicines” 
follows the goals of educational and professional 
training programs for graduates of Higher Medical 
Education Institution and is determined by the 
content of the systematic knowledge and skills that 
a pharmacist must comprehend. The knowledge that 
students receive during study the subject is the basis 
for block of subjects that provide professional and 
practical training. “Standardization of medicines” 
as a subject is based on previously studied by the 
students subjects such as “Pharmaceutical Chemistry”, 
“Drug technology”, “Pharmacognosy”. The subject 
“Standardization of medicines” is studied by the 
students on the 5th year in the 9th semester.
The study of the standardization of medicines 
forms in students a complete picture of the different 
quality indicators for assessing the quality of 
medicines depending on the type of dosage forms; 
the development of quality control methods, using 
pharmacopoeial methods of analysis that are used 
for quality control of  nished medicinal products; 
quality guidelines and other regulatory documents 
that ensure the appropriate level of  nished medicinal 
products’ quality, provide the fundamental knowledge 
and practical skills for future career of a pharmacist.
Lectures cover basic theoretical material of particular 
or more topics of the discipline, reveal the main issues 
of the relevant chapters of the discipline. Practical 
classes (seminar classes) envisage a detailed study 
by the students of some theoretical principles of 
the subject with the lecturer and the formation of 
ability and skills to their practical use by a student’s 
individual performance of various tasks and solving 
computational problems.
Students’ individual work involves mastering an 
educational material, such as an independent study of 
particular topics of the subject at the time free from 
mandatory training classes, and provides preparation 
to all types of control. Educational material of the 
subject that is envisaged by a curriculum for learning 
by the students during independent work is submitted 
for  nal control along with educational material that 
was worked up during the classes. 
Consultations (individual or group) are conducted to 
help students to understand and explain complicated 
issues for self-understanding, to solve complex 
problems arising during the independent learning of 
educational material in preparation for the practical 
trainings, or before differential credit. Matricula is 
considered to be passed when the student with full 
knowledge of the techniques independently, in strict 
sequence of work, performed practical skills and 
formulated conclusions competently. During the 
performing practical skills the lecturer has the right 
to direct the student who makes small errors and 
minor mistakes in carrying out the work. Matricula is 
considered not to be passed when the student knows 
the actual material, shows ignorance of the techniques, 
inability of practical skills, makes gross errors in the 
sequence of work and the formulation of conclusions.
Semester differential credit – it is a form of  nal 
control, which is to assess the mastering of educational 
material by a student on speci c subject on the basis 
of the results of the individual tasks performed and 
checking of mastering an educational program by a 
student.
Drug manufacturing control requires high level and 
intensive analytical and chemical support of all stages to 
ensure the drug’s quality and safety. The pharmacopeia 
constitutes a collection of recommended procedures 
for analysis and speci cations for the determination of 
pharmaceutical substances, excipients, and dosage forms 
that is intended to serve as source material for reference 
or adaptation by anyone wishing to ful ll pharmaceutical 
requirements. The most important analytical technique 
used during the various steps of drug development 
and manufacturing is the separation technique: High 
Performance Liquid Chromatography (HPLC).     
Drug development starts with the discovery of a 
molecule with a therapeutic value  ( g. 1). This can 
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Fig. 1. Drug development.
be done by high throughput screening during which 
separations by fast or ultra-fast HPLC are performed. 
At the discovery stage there can be also characterizing 
synthetic or natural products .  Drug metabolism and 
pharmacokinetics is the step where the candidate 
compounds for drug are tested for their metabolism and 
pharmacokinetics.  The studies involve use of LC-MS 
or LC-MS/MS [3, 4].  
The next stage is the development stage, where HPLC 
is used to characterize products of the chemical synthesis, 
by analyzing the active pharmaceutical ingredients (API), 
their impurities and/or degradation products generated 
by accelerated aging. The development of formulation 
requires also studies of the dissolution properties of solid 
dosage forms as well as assays of the pharmaceutical 
formulations.  Method for the veri cation of system’s 
cleanliness during the manufacturing process are 
developed and used at this stage. All the HPLC methods 
that have been  nalized at the developmental stage 
are validated and transferred to the manufacturing 
laboratories for a quality control analysis. 
During the last decade parallel synthesis of potential 
lead compounds, using combinatorial chemistry, has 
been done. The large numbers of products created by 
the combinatorial chemistry are then identi ed by fast 
LC-MS methods and screened by in-vitro bioassays 
and/or pharmacological or chemical tests to allow a 
selection of a few chosen drug candidates.  
When the lead compounds are selected, the next 
steps involve pharmacological studies. Due to its 
high sensitivity and selectivity, HPLC coupled with 
tandem mass spectrometry, HPLC-MS/MS, has 
become the predominant method in bioassays, and 
pharmacokinetic and metabolic studies.  In addition, 
another new development in this  eld has been the 
introduction of column’s packing with ultra-fine 
particles (<2 um) enabling short columns to be used 
(5 cm or less) and rapid analyses (e.g., 5 min or even 
less than 1 min) to be carried out by UPLC (ultra 
performance liquid chromatography).
The support of bioanalytical testing includes 
quantitation of a target compound in various biological 
matrices as part of preclinical lead optimization by 
measurement its adsorption, distribution, metabolism 
and excretion. The samples are physiological  uids such 
as plasma, serum, tissue extracts and urine, typically 
from experimental animals or human subjects. During 
the last decade conventional HPLC methods using 
 uorescence or electrochemical detection, following 
an elaborate sample clean-up, have been replaced by 
HPLC-MS/MS or UHPLC-MS/MS methodologies. 
Sample clean-up is simpler and more automated and 
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usually involves protein precipitation and/or solid 
phase extraction techniques.
The chromatographic method is typically very 
rapid, gradient or isocratic, using small columns’ 
dimensions, such as 2.1x50 mm or less.  A trace 
of a typically stable daughter ion signal, obtained 
from the fragmentation of a parent analyte is used 
for the detection and quantitation.  Such a mode is 
called MRM (multiple reaction monitoring) or SRM 
(selective reaction monitoring), which is more stable, 
sensitive and selective than either the  uorescence or 
electrochemical signal.  Samples are usually ordered 
in 96 microplates for higher throughput and minimum 
variability of the sample vials.  An internal standard 
is used typically to minimize assay variability, due to 
the clean-up stage and MS/MS response, which is still 
less stable than UV response.
All HPLC methods used for the development of 
pharmaceuticals and for the determination of their 
quality have to be validated. In cases whereby methods 
from the Pharmacopoeia’s are used, it is not necessary 
to evaluate their suitability, provided that the analyses 
are conducted strictly according to the methods’ 
intended use.  In most other cases, especially in cases 
of modi cation of the drug composition, the scheme 
of synthesis or the analytical procedure, it is necessary 
to re-evaluate the suitability of the HPLC method to 
its new intended use. 
The parameters tested throughout the method 
validation as de ned by the ICH, USP and FDA and 
other health organizations are the following: speci c-
ity or selectivity, precision, accuracy, linearity range, 
limit of detection, limit of quantitation and robustness. 
All this aspects students study in the subject “Stand-
ardization of medicines”. As a result of study the sub-
ject “Standardization of medicines” a student should 
know: structure of the Europiean (British) Pharmaco-
poeia; normative documents relating to the quality of 
medicines (guidelines, regulations, speci cations, tech-
nical speci cations, etc.); theoretical fundamentals of 
pharmacopoeial analysis methods; practical application 
of pharmacopoeial analysis methods in professional 
activities; the main quality indicators for assessing 
the quality of  nished medicinal products depending 
on the type of dosage form; primary and secondary 
pharmaco-technological parameters by which quality 
of medicines is assessed; types of speci cations and 
their use for professional activities; validation charac-
teristics during the validation of analytical methods; 
the structure of the quality control methods. 
Teachers are constantly working on improving the 
necessary teaching and methodological support of the 
discipline, they seek to acquire knowledge, practical 
skills, contribute to the formation of scienti c outlook, 
moral, aesthetic and other personal qualities, and the 
education of the team. They also focus on the needs of 
the student in certain knowledge, skills and abilities, 
based on further self-education, since the formation 
of the personality of a specialist does not end in an 
educational institution; it lasts for a lifetime during 
practical activity and continuous improvement of 
professional skills.
In countries of Middle East undergraduate students 
do not study “Standardization of medicines” but 
postgraduate students study subject “Pharmaceutical 
quality control and good laboratory practice” in Mas-
ter in Quality control and drug analysis. In this course, 
the basic concepts and philosophies of quality are dis-
cussed. Quality management systems and standards 
such as TQM, ISO, GMP is also included. In addition 
to statistical process control, quality control charts, 
process capability analysis, acceptance sampling plans 
and military standards are covered. This course also 
cover the quality assurance programs applied in phar-
maceutical practice and validation of these programs. 
Control programs for raw materials, in-process and 
 nished products are discussed. Sampling and sam-
pling programs, record handling and documentation 
are also included. So in our opinion, undergradu-
ate students must study subject which will prepare 
them for “Pharmaceutical quality control and good 
laboratory practice” and this subject is “Standardiza-
tion of medicines”.
Conclusions. To prepare the students, studying the 
discipline “Standardization of medicines”, integrating 
the laws and methods of many sciences, plays an 
important role in this discipline. It is a discipline that 
preserves the quality of medicines, and hence the 
health of the people. It allows students to systematize 
knowledge and practical skills and use them in their 
professional activities.
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